Kim IS - Search Results

1

Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.

Kwak G, Kim D, Nam GH, Wang SY, Kim IS, Kim SH, Kwon IC, Yeo Y. Kwak G, et al. Among authors: kim d, kim sh, kim is. ACS Nano. 2017 Oct 24;11(10):10135-10146. doi: 10.1021/acsnano.7b04717. Epub 2017 Oct 12. ACS Nano. 2017. PMID: 28985469 Free PMC article.

2

Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis.

Thapa N, Kim S, So IS, Lee BH, Kwon IC, Choi K, Kim IS. Thapa N, et al. Among authors: kim s, kim is. J Cell Mol Med. 2008 Sep-Oct;12(5A):1649-60. doi: 10.1111/j.1582-4934.2008.00305.x. Epub 2008 Mar 14. J Cell Mol Med. 2008. PMID: 18363834 Free PMC article.

3

Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3.

Kwon MK, Nam JO, Park RW, Lee BH, Park JY, Byun YR, Kim SY, Kwon IC, Kim IS. Kwon MK, et al. Among authors: kim sy, kim is. Mol Cancer Ther. 2008 Jun;7(6):1514-22. doi: 10.1158/1535-7163.MCT-07-2009. Mol Cancer Ther. 2008. PMID: 18566222

4

Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.

Hong HY, Lee HY, Kwak W, Yoo J, Na MH, So IS, Kwon TH, Park HS, Huh S, Oh GT, Kwon IC, Kim IS, Lee BH. Hong HY, et al. Among authors: kim is. J Cell Mol Med. 2008 Oct;12(5B):2003-14. doi: 10.1111/j.1582-4934.2008.00189.x. J Cell Mol Med. 2008. PMID: 19012727 Free PMC article.

5

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.

Choi KY, Yoon HY, Kim JH, Bae SM, Park RW, Kang YM, Kim IS, Kwon IC, Choi K, Jeong SY, Kim K, Park JH. Choi KY, et al. Among authors: kim is, kim jh, kim k. ACS Nano. 2011 Nov 22;5(11):8591-9. doi: 10.1021/nn202070n. Epub 2011 Oct 11. ACS Nano. 2011. PMID: 21967065

6

Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA.

Choi KM, Choi SH, Jeon H, Kim IS, Ahn HJ. Choi KM, et al. Among authors: kim is. ACS Nano. 2011 Nov 22;5(11):8690-9. doi: 10.1021/nn202597c. Epub 2011 Oct 13. ACS Nano. 2011. PMID: 21985460

7

Doxorubicin/heparin composite nanoparticles for caspase-activated prodrug chemotherapy.

Khaliq NU, Sandra FC, Park DY, Lee JY, Oh KS, Kim D, Byun Y, Kim IS, Kwon IC, Kim SY, Yuk SH. Khaliq NU, et al. Among authors: kim d, kim sy, kim is. Biomaterials. 2016 Sep;101:131-42. doi: 10.1016/j.biomaterials.2016.05.056. Epub 2016 Jun 2. Biomaterials. 2016. PMID: 27286189

8

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.

Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, Kim IS. Koh E, et al. Among authors: kim is. Biomaterials. 2017 Mar;121:121-129. doi: 10.1016/j.biomaterials.2017.01.004. Epub 2017 Jan 3. Biomaterials. 2017. PMID: 28086180

9

Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes.

Yang Y, Hong Y, Nam GH, Chung JH, Koh E, Kim IS. Yang Y, et al. Among authors: kim is. Adv Mater. 2017 Apr;29(13). doi: 10.1002/adma.201605604. Epub 2017 Feb 6. Adv Mater. 2017. PMID: 28165174

10

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.

Lee NK, Lee EJ, Kim S, Nam GH, Kih M, Hong Y, Jeong C, Yang Y, Byun Y, Kim IS. Lee NK, et al. Among authors: kim s, kim is. J Control Release. 2017 Dec 10;267:172-180. doi: 10.1016/j.jconrel.2017.08.014. Epub 2017 Aug 15. J Control Release. 2017. PMID: 28821462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,233 results

Search Page

Filters